Inhalation

INH0822

Issue link: https://www.e-digitaleditions.com/i/1475629

Contents of this Issue

Navigation

Page 22 of 38

Inhalation August 2022 21 Automated shake and fire benchtop systems e Vertus ® II and Vertus ® Plus are fully automated shake and fire benchtop systems for precision- controlled, highly repeatable metered dose inhaler (MDI) and nasal spray testing. Supporting both delivered dose uniformity (DDU) and aerodynamic particle size distribution (APSD) testing applications, the interchangeable interface plates offer analysts the flexibility to choose from a range of collection devices, while streamlining complex testing work- flows. Enhance the sensitivity of your data and keep testing simple and repeatable with the Vertus range from Copley Scientific. See the systems in action: youtu.be/KdibZi6L6DQ. Copley Scientific UK: +44 1159 616229 sales@copleyscientific.co.uk www.copleyscientific.com Spray and aerosol characterization With over 25 years of experience supporting the devel- opment and release of orally inhaled and nasal drug products (OINDPs), Proveris Scientific is strongly positioned to bring value to all stages of your drug development and commercialization process. Proveris Laboratories is a cGMP test laboratory that provides specialized services, including plume front velocity and spray duration for developing submission-ready data. In addition, the Vereo ® Automated Actuator and SprayVIEW ® Systems are "gold standard" mea- surement systems for OINDPs and are supported by our applications and technical support teams. Proveris Scientific Corporation US: +1 505 460-8822 contactus@proveris.com www.proveris.com An aerosol optical tweezers e Biral AOT-100 (Aerosol Optical Tweezers) enables non-specialists, such as laboratory scientists, students and technical staff, to explore the phys- ical and chemical behavior of individual micron- sized droplets with extraordinary precision. Initially, the instrument was predominantly used as a reli- able research tool to further the understanding of atmospheric and environmental aerosol. However, advances enable the AOT-100 to be applied to phar- maceutical research. is research looks to resolve the microphysical changes affecting pharmaceutical drop- lets as they enter the humid environment of the lung, with the aim of improving the delivery and efficacy of inhalation therapy products. Biral UK: +44 1275 847787 www.biral.com

Articles in this issue

Links on this page

view archives of Inhalation - INH0822